Back to Results
First PageMeta Content



Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in patients (pts) with recurrent platinum-sensitive ovarian cancer (OC) Roisin O’Cearbhaill1, Scott McM
Add to Reading List

Document Date: 2016-06-05 05:57:06


Open Document

File Size: 751,37 KB

Share Result on Facebook